Brief: Celsion Corporation Highlights Pipeline Progress In Its Lead Development Candidates

Imunon

10/05/2022 13:54

May 10 (Reuters) - Celsion Corp  CLSN.O :
    * CELSION CORPORATION HIGHLIGHTS PIPELINE PROGRESS IN ITS
LEAD
DEVELOPMENT CANDIDATES
    * CELSION CORP - PHASE II STUDY OF GEN-1 IN OVARIAN CANCER
85%
ENROLLED WITH FULL ENROLLMENT EXPECTED IN Q3 OF 2022

Source text for Eikon:  ID:nGNX9YrxMy 
Further company coverage:  CLSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))